CD44, a widely accepted marker for cancer stem cells and a mesenchymal marker regulating both stemness and epithelial-mesenchymal plasticity, was shown to be predominantly upregulated in CEGBCs-DB (Fig. 2h). This evidence concerns the gene CD44 and cancer.